MedTrace Logo

FX Shoulder Solutions Retrospective / Prospective Clinical Study

NCT06077942 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2023-10-12

No results posted yet for this study

Summary

Subjects implanted with the shoulder replacement medical devices manufactured by FX Shoulder Solutions and distributed by FX Shoulder Solutions.

Conditions

  • Rotator Cuff Syndrome of Shoulder and Allied Disorders
  • Osteoarthritis Shoulder
  • Fracture, Shoulder

Interventions

DEVICE

FX Artificial Shoulder Prosthesis

Humelock II Anatomic Shoulder System, Humelock II Reversible Shoulder System, Humelock Reverse Shoulder System, Humeris Shoulder System, Easytech Anatomical Shoulder System, PRCT II Fracture Plate, V-135

Sponsors & Collaborators

  • FX Shoulder Solutions

    lead INDUSTRY

Principal Investigators

  • Brian Rogers, BS · FX Shoulder Solutions

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-06
Primary Completion
2032-12-30
Completion
2032-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06077942 on ClinicalTrials.gov